SEC Form 4 research
| Issuer | VERTEX PHARMACEUTICALS INC / MA |
|---|---|
| Tickers | VRTX |
| Reporting owners | 62 |
| Officers and directors | 52 |
| Last public filing | 2026-10-22 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-22 | 2026-10-20 | Brennan Daniel J. | A | 795 | $503.47 | Not reported |
| 2026-10-19 | 2026-10-15 | SACHS BRUCE I | A | 92.69 | $512.44 | Not reported |
| 2026-10-19 | 2026-10-15 | Garber Alan M | A | 29.27 | $512.44 | Not reported |
| 2026-09-10 | 2026-09-08 | van Grunsven Jasper | A | 8,682 | $0 | Not reported |
| 2026-09-01 | 2026-08-28 | Ambrose Kristen | A | 5,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.